Adam Kittai
Director, Director, CLL Program, Perlmutter Cancer Center · NYU Grossman School of Medicine
Credentials: · · · · · · · ·
History
PresentDirector · NYU Grossman School of Medicine
- Present
NYU Grossman School of Medicine · NYU Grossman Long Island School of Medicine
- 2008–2012
Faculty of Medicine
Research
Immune Checkpoint Inhibitors in Organ Transplant Patients
Case report · Journal of Immunotherapy · 2017 · First of 4 authors · 128 citations
Review · JACC CardioOncology · 2023 · 114 citations
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib
Cancer · 2018 · 81 citations
31 papers
- KR
27 papers
27 papers
- JB
22 papers
- AD
21 papers
- MG
15 papers
11 papers
10 papers
Clinical trials
- 2023–2026
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
Site PI · Recruiting · Phase 2
Aseel Alsouqi
- 2022–2026
Site PI · Recruiting · Phase 2
Ohio State University Comprehensive Cancer Center
- 2021–2027
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Site PI · Recruiting · Phase 2
Weill Medical College of Cornell University